Jay Ushin (513252)
CyclicalScore breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹775 |
| Market Cap | ₹303.2 Cr |
| P/E Ratio | 21.48 |
| ROCE | 12.76% |
| ROE | 13.42% |
| Dividend Yield | 0.47% |
| Profit Growth | 29.13% |
| Debt/Equity | — |
| Sales Growth | 12.17% |
| 52-Week Range | ₹641.7 — ₹1,601.75 |
| Sector | Auto Components |
| Book Value | ₹321.47 |
Strengths
- Sales growth of 12.17% and profit growth of 29.13% show positive operating momentum.
- Piotroski F-Score of 7/9 suggests sound fundamentals and low near-term distress risk.
- ROE of 13.42% and ROCE of 12.76% are respectable for a small auto-component maker.
- PEG of 1.04 implies the valuation is not excessive if the growth persists.
Concerns
- Latest quarter net profit of ₹4 Cr on ₹245 Cr sales translates to a razor-thin ~1.6% net margin.
- Debt/Equity and promoter holding data are missing, reducing transparency.
- At ₹775, the stock is well below its 52-week high of ₹1,601.75, which can signal a cyclical downturn or value trap.
- P/E of 21.48 and P/B of 2.41 leave limited margin of safety for a cyclical with no clear moat.
AI Analysis
At ₹775, Jay Ushin is a small auto-component player with a mixed report card. The market cap is only ₹303 crore, so I demand a margin of safety. A P/E of 21.48 and P/B of 2.41 are not cheap for a business that earned just ₹4 crore in the latest quarter on ₹245 crore of sales. That is roughly a 1.6% net margin; in a cyclical industry like auto components, such thin margins can vanish quickly. Graham would ask what I am really buying. Book value is ₹321.47, so I am paying ₹775 for assets that earn 13.42% on equity. That is decent, but not exceptional. Sales are growing at 12.17%, and profit growth is 29.13%; the PEG of 1.04 suggests that growth is almost fully reflected in the price. The Piotroski score of 7/9 is a positive, indicating the company is not financially strained. However, the missing debt/equity and promoter holding figures bother me. When data is absent, I assume the worst. Also, the stock has fallen from ₹1,601.75 to ₹775; a 52-week low price can be a value trap, not an opportunity. This looks like a cyclical business without a durable moat, not a wonderful franchise. I want to see stronger margins, lower leverage, and proof that 29% profit growth is repeatable before I invest. At this price, the margin of safety is still too thin for my taste.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer